Recent

% | $
Quotes you view appear here for quick access.

Regenerx Biopharmaceuticals Inc. Message Board

  • donker3 donker3 Mar 25, 2013 10:02 AM Flag

    What's also interesting.........

    Is JJ announced the China heart patent at the same time the FDA changed their criteria........

    That way if anyone bought on the FDA info it would appear they bought on the China patent.....

    JJ's an extremely wiley critter or a bumbling idiot. No in between.

    Trade accordingly......

    The Donker

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • the China issued heart patent has nothing to do with the FDA Orphan Drug status of the EB trial. That patent means little, cuz there isn't any money for a heart trial. Something is going on behind the scens with EB and the FDA Orphan Drug dept. There is precident for them okaying approval based on a phs 2 trial, for an Orphan designated drug, if it warrants. WHY did the FDA change the trial wording/design? Look. Feb 6. FDA had results IN HAND! We don't.

 
RGRX
0.4599-0.0001(-0.02%)Feb 8 3:10 PMEST